LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 265 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 2.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $17,907,000 | -27.5% | 246,251 | +4.0% | 3.08% | +8.2% |
Q4 2019 | $24,702,000 | -27.3% | 236,862 | -30.7% | 2.84% | -2.8% |
Q3 2019 | $33,998,000 | +23.5% | 341,554 | +41.7% | 2.92% | +42.1% |
Q2 2019 | $27,523,000 | +4.3% | 241,110 | +14.9% | 2.06% | +8.1% |
Q1 2019 | $26,377,000 | +111.3% | 209,823 | +128.1% | 1.90% | +83.6% |
Q4 2018 | $12,482,000 | -28.1% | 91,984 | +45.4% | 1.04% | +10.6% |
Q3 2018 | $17,365,000 | -1.5% | 63,263 | -25.6% | 0.94% | -3.4% |
Q2 2018 | $17,627,000 | +5.1% | 85,083 | -16.2% | 0.97% | -1.0% |
Q1 2018 | $16,773,000 | -9.0% | 101,556 | -24.6% | 0.98% | -9.6% |
Q4 2017 | $18,438,000 | +3.5% | 134,650 | +2.9% | 1.08% | -3.4% |
Q3 2017 | $17,823,000 | +9.7% | 130,905 | -2.2% | 1.12% | +6.7% |
Q2 2017 | $16,241,000 | +4.1% | 133,782 | -9.3% | 1.05% | +10.2% |
Q1 2017 | $15,605,000 | +34.3% | 147,437 | +28.9% | 0.96% | +21.8% |
Q4 2016 | $11,618,000 | -8.4% | 114,339 | -8.0% | 0.78% | -6.2% |
Q3 2016 | $12,686,000 | – | 124,301 | – | 0.84% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $7,682 | 2.90% |
VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |